Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.
about
Neuronal effects of nicotine during auditory selective attention in schizophreniaDown-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept studyFunctional magnetic resonance imaging of intrinsic brain networks for translational drug discoveryIncreased hippocampal CA1 cerebral blood volume in schizophrenia.Could vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia?GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.Increased Amplitude of Low Frequency Fluctuations but Normal Hippocampal-Default Mode Network Connectivity in SchizophreniaIn search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia.Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in SchizophreniaFrontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.Brain circuit dysfunction in a distinct subset of chronic psychotic patients.Fronto-temporal connectivity predicts cognitive empathy deficits and experiential negative symptoms in schizophrenia.Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice.Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.Hippocampal GABA enables inhibitory control over unwanted thoughts.Combining multi-modality data for searching biomarkers in schizophrenia.The hippocampal network model: A transdiagnostic metaconnectomic approach.Evaluation of cognitive and social functioning in patients requiring long-term inpatient psychiatric care using the International Classification of Functioning, Disability, and Health: a large-scale, multi-institutional observational study.Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice.Karolinska Scales of Personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls.Altered Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Schizophrenia.Nicotinic modulation of salience network connectivity and centrality in schizophrenia.Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia.Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication.Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia.Effects of theta-rhythm transcranial alternating current stimulation (4.5 Hz-tACS) in patients with clozapine-resistant negative symptoms of schizophrenia: a case series.Hippocampal Neural Disinhibition Causes Attentional and Memory Deficits.Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.Hippocampal Pathophysiology: Commonality Shared by Temporal Lobe Epilepsy and Psychiatric Disorders.Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivityOptogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptomsMultimodal neuromarkers in schizophrenia via cognition-guided MRI fusion
P2860
Q30366764-76F9B271-B533-45E1-951C-DFE03A1C28F5Q30368373-344735A0-BB18-4A3A-BD74-8D37FC367DC8Q30368931-9FDA6E95-1B23-4F51-9C0C-138B8D6A6745Q30829551-B30E4C21-D6E4-4157-9F2F-B7304C13C0F5Q34079242-402DA110-DD56-4581-B671-5D4E87069998Q35211484-64332AEA-0DD0-42E0-9AB8-E3520EDB59F2Q35469889-21AC86D7-40A6-4614-BF3C-4FCDA1A63DEDQ35687971-76A189FD-1792-46B4-BDD2-A0C74D259D0EQ35773382-5DE94980-E2CD-4701-92B6-99C9B83E0F9EQ35991741-B96873FE-0BB1-4593-AEDB-A0E5D7E9A794Q36604589-0C2AE1D2-F0C4-45B6-A293-15395CD5EAEFQ36661099-440EC1ED-8090-473D-95F4-986AA782E01FQ36950595-DF814E57-9873-4372-B861-D143AC4FB9EDQ36994859-1778F2E4-F161-4253-A61F-9990B2EAC1A8Q37198435-155279D2-2D2D-4FE9-9C07-008C0BB12197Q37510500-72DDA23F-03E8-4E57-9A45-BC81AD5D925AQ37547506-D74D9547-8FB9-45BC-8B42-7602E742FCD8Q38226241-4C0133AD-619D-4487-91E7-EFBB83B2E16DQ39255957-8D303137-67F4-4395-92A3-958F25612690Q39287296-F3C17242-B4E2-448D-92E1-A7BC098AC89CQ41892321-99CA359C-77D2-4159-B15D-5566BCFFCF94Q46058577-CE2D3373-8FD1-4291-ADE2-0D6661B61A34Q47157251-E7EB1157-3B7E-40C2-8EF7-F3331F648956Q47553516-246675D9-65A0-4899-89BB-08215859B794Q47553885-97471CCE-DCAB-4EB0-827B-F677BF2B6163Q47558277-D6034601-4A5D-4272-85C5-E67E2C810D74Q47572745-A986CB6B-AC45-4E52-81BA-B6BC731B3AFFQ47683336-DEB5933A-82A2-45B3-8D5F-5FBCFA70222DQ47719299-6A39E9D4-6B20-49D5-848A-A53161FF1970Q47973579-18C56680-3EA3-451F-91DC-F66249743D52Q48016632-027B127C-16F7-4601-A71C-FAA41D7B7832Q48413208-EE9F5D31-F809-430D-A423-70BBDFD45632Q48647823-657AC4CC-5F27-463D-94B6-3ECC8120DE6DQ48726429-760905AD-737B-404B-A9A6-E72DE1FE6A7FQ50491498-5A5A552D-6228-4225-BF46-4C74FBF77A81Q50578569-2C86FC42-2E20-4A0B-B256-D018BC7B940EQ55016099-5C94C49A-328C-45A3-B531-2D3290772ACEQ57292683-C3AE264A-5E3F-492B-A5A7-22FFE60A45BAQ58701316-6F6DDA0D-A1E5-4F1C-9578-6B33D2B1810CQ58803583-277BA1C3-F697-42BB-B754-B3AD8B3CC714
P2860
Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@ast
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@en
type
label
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@ast
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@en
prefLabel
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@ast
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@en
P2093
P2860
P1476
Intrinsic hippocampal activity ...... and symptoms in schizophrenia.
@en
P2093
Emma Lyons
Eugene Kronberg
Jason R Tregellas
Josette G Harris
Keeran Maharajh
Lindsay C Eichman
Robert Freedman
P2860
P304
P356
10.1176/APPI.AJP.2013.13070981
P407
P577
2014-05-01T00:00:00Z